Arrow International epidural catheter kits recalled for potentially compromised anesthetic sterility
Arrow International epidural kits recalled for sterility concerns
Arrow International included anesthetic medications (lidocaine, bupivacaine) and saline from a supplier with quality issues in multiple epidural catheter kits. The supplier's products may not be sterile or effective, and compromised sterility in injectable products can cause serious infection or other life-threatening complications.
- If you use these kits in a medical facility, check your inventory against the affected lot numbers listed in the FDA notice
- Do not use recalled kits; return them to your distributor or Arrow International
- Contact your healthcare provider or facility's pharmacy if you have questions about specific lot numbers
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2371-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief